Back | Next |
home / stock / cerc / cerc message board
Subject | By | Source | When |
---|---|---|---|
News out today read here: Cerecor and | Jcbaby1 | investorshub | 05/26/2020 11:55:35 AM |
looks like they acquired product lines and not | Chrisny73 | investorshub | 04/30/2020 6:26:11 PM |
according to the SEC doc. $AYTU acquired$ CERC | TheFinalCD | investorshub | 04/30/2020 6:03:58 AM |
Yeah. I used to have this under a | tonyjh | investorshub | 04/24/2020 12:52:53 AM |
Looks like this stock took a beating after | Chrisny73 | investorshub | 04/23/2020 7:21:16 PM |
Gnmx aquired by Cerc!! on our way up!!! | StocktonCA | investorshub | 02/06/2020 5:51:23 PM |
$7-$8 coming | sanderburwil | investorshub | 12/11/2019 5:10:21 PM |
This company is going to be exciting soon | jcbaby | investorshub | 08/14/2019 7:52:50 PM |
News: $CERC Cerecor Reports Second Quarter 2019 Results | whytestocks | investorshub | 08/08/2019 8:30:26 PM |
News: $CERC Cerecor Announces Positive Final Results of | whytestocks | investorshub | 07/01/2019 12:20:25 PM |
News: $CERC Cerecor Added to Russell 3000® Index | whytestocks | investorshub | 06/28/2019 4:50:27 PM |
News: $CERC Cerecor Set to Join Russell 3000® Index | whytestocks | investorshub | 06/11/2019 6:10:40 PM |
Anybody out there following this growing company? | FreedFish | investorshub | 11/24/2018 3:35:23 PM |
Beast | JBowsNose | investorshub | 03/07/2018 10:48:59 PM |
$CERC buy 4.93 | stocktrademan | investorshub | 03/03/2018 6:51:52 PM |
$CERC about to Break 52 week high | europtiger | investorshub | 02/19/2018 1:58:59 PM |
Bullish triangle breakout on 15-Feb-2018 | pietro13 | investorshub | 02/16/2018 5:46:23 PM |
Whatever is happening to this market, I'm glad | cash_cow1 | investorshub | 02/06/2018 1:25:34 PM |
Hedge funds loading. | crudeoil24 | investorshub | 01/23/2018 5:25:33 PM |
Weeee | europtiger | investorshub | 01/23/2018 4:34:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Appointments include industry veterans Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent Directors Board of Director appointments in conjunction with Avalo’s recent acquisition of AVTX-009, an anti-IL-1β mAb, and up to $185 million private placement financ...
Acquired AVTX-009, Phase-2 ready anti-IL-1β mAb, in March 2024 Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront investment of $115.6 million Topline results from planned Phase 2 trial of AVTX-00...
Avalo acquires Phase 2-ready anti-IL-1β mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026 Executed private placement financing of up to $185 million, including initial upfront invest...